Home
Nation
States
International
Politics
Defence & Security
Opinion
Economy
Sports
Entertainment
Trending:
July 31, 2024, 09:01 PM - 2 min read
Extensive clinical trials have rigorously evaluated the safety and immunogenicity of the vaccine--nOPV2, leading to promising results published in The Lancet (2019-2024).